Dan Sharp
Inflammatory Bowel Disease advocate
Twitter Instagram Facebook
 
Skip to content
  • Articles
  • Resources
    • Articles
    • Pharmaceutical Financial Assistance
    • Free Restroom Access Cards
    • Camps for Kids with IBD
  • About Me
  • Contact Me
  • Events
    • How to Join a Twitter Chat
    • University of Michigan’s Virtual Patient-2-Patient Education Project (Oct 3, 2020)
    • #GutOverHere – patient meetups
    • Camps for Kids with IBD

Category: Twitter

No comments

How to Join a Twitter Chat

  By Dan Sharp July 19, 2018 July 12, 2019 Articles, Events, F.A.Q., Twitter
how to join a twitter chat   Twitter chats can be a great way to participate in discussions about important topics, and to find new connections within various patient and medical communities. There…
No comments

IBD Social Circle Chat – “Intimacy & Dating with IBD” – October 16 @ 8pm ET

  By Dan Sharp October 16, 2017 July 1, 2018 Advocacy, Events, News, Twitter
Intimacy & Dating With IBD The IBD Social Circle is hosting a twitter chat on Monday, October 16th at 8pm ET. The topic for this chat is Intimacy and Dating with…
  • Content Categories

  • Recent Posts

    • U of Michigan’s Patient-2-Patient Education Project 2021
    • That’s Not “Chemo” (The Mislabeling of IBD Treatments)
    • The University of Michigan’s Patient-2-Patient Education Project
    • Logical Fallacies in Online Patient Groups
    • How to Join a Twitter Chat
  • Twitter

    Dan SharpFollow

    Patient advocate | Medical Laboratory Scientist🔬 (ASCP) | #DisruptiveInnovator | Interests include cats, stats, & science-based medicine | #IBD

    Dan Sharp
    Retweet on TwitterDan Sharp Retweeted
    ibddoctorPeter Higgins@ibddoctor·
    12 May

    The delta of 33% for clinical remission by CDAI is pretty impressive, especially with a lot of bio-experienced patients. Larger than IFX in the bionaive era in ACCENT. https://twitter.com/mchiorean4/status/1524768083285405697

    Michael Chiorean@mchiorean4

    Upadacitinib (selective JAK1-inhibitor) achieved all clinical & endoscopic endpoints for maintenance in #CrohnsDisease in the phase 3 program. Number needed to treat of 3 for clinical and 4 for endoscopic endpoints. Great news for our #IBD patients https://news.abbvie.com/news/press-releases/upadacitinib-rinvoq-achieved-clinical-remission-and-endoscopic-response-at-one-year-in-phase-3-maintenance-study-in-patients-with-crohns-disease.htm?view_id=2421

    Reply on Twitter 1524770614963322880Retweet on Twitter 152477061496332288013Like on Twitter 152477061496332288052Twitter 1524770614963322880
    Retweet on TwitterDan Sharp Retweeted
    MikeKattahMDKattahLab@MikeKattahMD·
    23 Apr

    Breaking therapeutic ceiling in UC With Upa @ibddoctor @TimSimpsonMD @UCDavisGI @rkhsusa @ucsfibd

    Reply on Twitter 1517893773316952064Retweet on Twitter 15178937733169520647Like on Twitter 151789377331695206435Twitter 1517893773316952064
Copyright Dan Sharp 2018. Disclaimer
Powered by Parabola & WordPress.
Twitter Instagram Facebook